Back to Journals » OncoTargets and Therapy » Volume 9

JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway

Total article views   HTML views PDF downloads Totals
5,938 Dovepress* 5,326+ 1,262 6,588
PubMed Central* 612 144 756
Totals 5,938 1,406 7,344
*Since 20 July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar